日本語フィールド
著者：○Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Takamori A, Tajiri R, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai K題名：Ipragliflozin Ameliorated Overweight and Pathological Liver Fibrosis in Diabetic Patients with Nonalcoholic Fatty Liver Disease in a Multicenter Randomized Controlled Trial.発表情報：ADA 80th Scientific Sessions （Virtual Meeting）, 2020, 6, 12-16キーワード：概要：抄録：Diabetes 2020 Jun; 69 (Supplement 1): 31-OR英語フィールド
Author：○Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Takamori A, Tajiri R, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai KTitle：Ipragliflozin Ameliorated Overweight and Pathological Liver Fibrosis in Diabetic Patients with Nonalcoholic Fatty Liver Disease in a Multicenter Randomized Controlled Trial.Announcement information:ADA 80th Scientific Sessions （Virtual Meeting）, 2020, 6, 12-16An abstract：Diabetes 2020 Jun; 69 (Supplement 1): 31-OR